X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,450 | 2,371 | 39,067 | -51,766 | -101,167 |
| Depreciation Amortization | 796 | 523 | 256 | 62 | 419 |
| Accounts receivable | -1,070 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -286 | -364 | -944 | 4 | 1,234 |
| Other Working Capital | 2,675 | 1,479 | 3,138 | 2,090 | 344 |
| Other Operating Activity | -95,566 | -101,915 | -105,391 | 16,013 | 2,658 |
| Operating Cash Flow | $-130,901 | $-97,906 | $-63,874 | $-33,597 | $-96,512 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 104,674 | 104,715 | 104,807 | -59 | -60 |
| Purchase Of Investment | -57,134 | -34,354 | -13,267 | -10,263 | -16,823 |
| Sale Of Investment | 26,450 | 12,250 | 7,000 | 5,000 | 2,000 |
| Purchase Sale Intangibles | -7,000 | -7,000 | -7,000 | N/A | N/A |
| Other Investing Activity | -7,000 | -7,000 | -7,000 | 0 | 0 |
| Investing Cash Flow | $66,990 | $75,611 | $91,540 | $-5,322 | $-14,883 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 20,000 | 20,000 | N/A | 22,500 |
| Debt Repayment | N/A | N/A | N/A | N/A | -2,064 |
| Common Stock Issued | 294 | 159 | 159 | N/A | 68,711 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -631 |
| Financing Cash Flow | $20,294 | $20,159 | $20,159 | $N/A | $88,516 |
| Exchange Rate Effect | -156 | 88 | -77 | -59 | 99 |
| Beginning Cash Position | 100,248 | 100,248 | 100,248 | 100,248 | 123,028 |
| End Cash Position | 56,475 | 98,200 | 147,996 | 61,270 | 100,248 |
| Net Cash Flow | $-43,773 | $-2,048 | $47,748 | $-38,978 | $-22,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,901 | -97,906 | -63,874 | -33,597 | -96,512 |
| Capital Expenditure | -326 | -285 | -193 | -59 | -60 |
| Free Cash Flow | -131,227 | -98,191 | -64,067 | -33,656 | -96,572 |